ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

TRML Tourmaline Bio Inc

15.55
-0.23 (-1.46%)
08 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Tourmaline Bio Inc TRML NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.23 -1.46% 15.55 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.78 15.30 15.89 15.55 15.78
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/4/202406:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
19/3/202406:00GLOBETourmaline Bio Reports Fourth Quarter and Full Year 2023..
27/2/202406:30GLOBETourmaline Bio to Present at Upcoming Investor Conferences
14/2/202420:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202419:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202415:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202407:00GLOBETourmaline Bio to Present at the Guggenheim Healthcare Talks..
29/1/202415:01GLOBETourmaline Bio Announces Closing of $172.5 Million Public..
26/1/202415:12EDGAR2Form 8-K - Current report
26/1/202415:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/1/202406:00GLOBETourmaline Bio Announces Pricing of Public Offering of..
24/1/202420:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/1/202416:10EDGAR2Form 8-K - Current report
24/1/202415:05GLOBETourmaline Bio Announces Proposed Public Offering of Common..
08/1/202408:19EDGAR2Form 8-K - Current report
08/1/202406:00GLOBETourmaline Bio Announces Expected Upcoming Key Milestones..
15/12/202315:00GLOBETourmaline Bio added to the NASDAQ Biotechnology Index
14/12/202307:27EDGAR2Form 8-K - Current report
14/12/202306:30GLOBETourmaline Bio Appoints Dr. Clay Siegall as Chairman of the..
30/11/202307:25EDGAR2Form 8-K - Current report
01/11/202307:00GLOBETourmaline Bio to Present at Upcoming Investor Conferences
23/10/202319:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202319:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202319:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202319:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202319:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202317:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/10/202316:37GLOBETourmaline Bio Announces Closing of Merger with Talaris..

Su Consulta Reciente

Delayed Upgrade Clock